Nephrotic Syndrome: Edema, Clot Risk, Infection | MDster You are offline Back online! [ MDster home ](/ "MDster home") Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ SOE Examiner NEW ](https://mdster.com/soe-examiner) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) Menu Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ SOE Examiner NEW ](https://mdster.com/soe-examiner) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) [ Login ](https://mdster.com/auth/login) 1. [ Home ](https://mdster.com) 2. [ Blog ](https://mdster.com/blog) 3. [ Medical Education ](https://mdster.com/blog?category=medical-education) 4. Nephrotic Syndrome: Managing Edema, Clot Risk, and Infection [ Medical Education ](https://mdster.com/blog?category=medical-education) Nephrotic Syndrome: Managing Edema, Clot Risk, and Infection ============================================================== A practical approach to the complications that turn heavy proteinuria into an urgent clinical problem [ MDster Editorial Team ](https://mdster.com/about) · Oct 01, 2026 · 5 min read · 52 [ Reviewed by Dr. Ali Ragab, MBBCH, MSc, MCAI ](https://mdster.com/medical-reviewers/dr-ali-ragab) [Editorial Policy](https://mdster.com/editorial-policy) | [Corrections Policy](https://mdster.com/corrections) [ Internal Medicine ](https://mdster.com/blog?tag=internal-medicine) [ Nephrology ](https://mdster.com/blog?tag=nephrology) [ Glomerular Disease ](https://mdster.com/blog?tag=glomerular-disease) [ Proteinuria ](https://mdster.com/blog?tag=proteinuria) ![Nephrotic Syndrome: Managing Edema, Clot Risk, and Infection](https://mdster.com/storage/blog/images/nephrotic-syndrome-managing-edema-clot-risk-and-infection.png) Share this article Share this post On this page 1. [ Start With the Proteinuria—Then Assess the Patient ](#start-with-the-proteinuria-then-assess-the-patient) 2. [ A threshold is not the whole syndrome ](#a-threshold-is-not-the-whole-syndrome) 3. [ Treat Edema Without Causing AKI ](#treat-edema-without-causing-aki) 4. [ Think sodium balance and circulating volume ](#think-sodium-balance-and-circulating-volume) 5. [ Anticipate the Complications That Change the Plan ](#anticipate-the-complications-that-change-the-plan) 6. [ Thrombosis: risk-stratify, do not anticoagulate by reflex ](#thrombosis-risk-stratify-do-not-anticoagulate-by-reflex) 7. [ Infection: distinguish disease risk from treatment risk ](#infection-distinguish-disease-risk-from-treatment-risk) 8. [ Key Takeaways ](#key-takeaways) 9. [ Conclusion ](#conclusion) 10. [ Frequently Asked Questions ](#blog-faqs) 11. [ References ](#references-heading) On this page 1. [ Start With the Proteinuria—Then Assess the Patient ](#start-with-the-proteinuria-then-assess-the-patient) 2. [ A threshold is not the whole syndrome ](#a-threshold-is-not-the-whole-syndrome) 3. [ Treat Edema Without Causing AKI ](#treat-edema-without-causing-aki) 4. [ Think sodium balance and circulating volume ](#think-sodium-balance-and-circulating-volume) 5. [ Anticipate the Complications That Change the Plan ](#anticipate-the-complications-that-change-the-plan) 6. [ Thrombosis: risk-stratify, do not anticoagulate by reflex ](#thrombosis-risk-stratify-do-not-anticoagulate-by-reflex) 7. [ Infection: distinguish disease risk from treatment risk ](#infection-distinguish-disease-risk-from-treatment-risk) 8. [ Key Takeaways ](#key-takeaways) 9. [ Conclusion ](#conclusion) 10. [ Frequently Asked Questions ](#blog-faqs) 11. [ References ](#references-heading) A patient arrives with swollen legs, foamy urine, and an albumin of 2.0 g/dL. It is tempting to write “nephrotic syndrome,” prescribe furosemide, and move on. Pause: the protein loss needs confirmation, the edema needs careful volume assessment, and the patient may be at risk of a clot or serious infection. [\[1\]](#cite-1 "Reference [1]") Start With the Proteinuria—Then Assess the Patient -------------------------------------------------- ### A threshold is not the whole syndrome **Nephrotic-range proteinuria** conventionally means more than 3.5 g of total urinary protein per day in adults. A spot urine protein-to-creatinine ratio (UPCR) of approximately 3.5 g/g often serves as a practical estimate; use a timed collection when the result and clinical picture disagree or precise quantification will change management. Do not confuse UPCR, which estimates *total protein*, with a urine albumin-to-creatinine ratio, which measures albumin. [\[2\]](#cite-2 "Reference [2]") Heavy proteinuria alone does not establish the full clinical syndrome. Look for hypoalbuminemia and edema, while remembering that presentation varies; hyperlipidemia and lipiduria can add support. Urine microscopy matters: prominent dysmorphic hematuria or red-cell casts suggest an inflammatory glomerular process rather than an uncomplicated nephrotic presentation. [\[3\]](#cite-3 "Reference [3]") - Confirm protein loss and check serum albumin, creatinine, electrolytes, blood pressure, and urine sediment. - Review diabetes, autoimmune disease, infections, malignancy clues, and medications; investigate likely secondary causes. - In an adult with unexplained nephrotic syndrome, involve nephrology to determine whether kidney biopsy will guide treatment. Do not start disease-specific immunosuppression merely because the UPCR is high. [\[4\]](#cite-4 "Reference [4]") > **Clinical Pearl:** A UPCR above 3.5 g/g tells you how much protein is escaping—not whether the patient needs anticoagulation or which glomerular disease to treat. [\[4\]](#cite-4 "Reference [4]") Treat Edema Without Causing AKI ------------------------------- ### Think sodium balance and circulating volume Nephrotic edema reflects renal sodium retention as well as the effects of hypoalbuminemia. A patient can have substantial peripheral edema yet be vulnerable to intravascular volume depletion. Before escalating diuretics, assess blood pressure, orthostatic symptoms, weight trend, urine output, and kidney function; do not treat leg appearance as a substitute for volume assessment. [\[1\]](#cite-1 "Reference [1]") Start with dietary sodium restriction to **less than 2 g of sodium daily** and a loop diuretic when edema warrants drug treatment. Track daily weights, symptoms, creatinine, sodium, and potassium while adjusting therapy. Routine water restriction is unnecessary unless a separate indication, such as hyponatremia, exists. [\[1\]](#cite-1 "Reference [1]") - If oral response is poor, first check sodium intake, adherence, and absorption; bowel-wall edema may impair oral diuretic delivery. - Consider an intravenous loop diuretic for persistent edema. A thiazide-type agent can help resistant cases, but monitor closely for electrolyte depletion and AKI. - Do not give intravenous albumin reflexively. Its diuretic benefit in adults is uncertain and often transient; reserve consideration for selected severe, diuretic-resistant cases with specialist input. [\[1\]](#cite-1 "Reference [1]") For longer-term proteinuria reduction, an ACE inhibitor or ARB may be appropriate when kidney function and hemodynamics are stable. In abrupt-onset nephrotic syndrome with possible volume depletion or rapidly changing GFR, do not initiate one automatically: these drugs can worsen AKI. Treat the underlying glomerular disease once it is identified. [\[5\]](#cite-5 "Reference [5]") Anticipate the Complications That Change the Plan ------------------------------------------------- ### Thrombosis: risk-stratify, do not anticoagulate by reflex Urinary loss of anticoagulant proteins, increased hepatic clotting-factor synthesis, and other changes contribute to hypercoagulability. DVT, pulmonary embolism, and renal vein thrombosis deserve attention; membranous nephropathy carries particularly high thrombotic risk. A falling serum albumin heightens concern, but no single albumin value mandates prophylaxis for everyone. [\[4\]](#cite-4 "Reference [4]") Ask about pleuritic pain, dyspnea, unilateral leg swelling, and new flank pain or hematuria. **Confirmed thrombosis requires therapeutic anticoagulation** unless contraindicated. For primary prophylaxis, weigh clot risk against bleeding risk with nephrology; consider the underlying lesion, albumin, proteinuria, prior thrombosis, immobility, and upcoming procedures. Do not apply a membranous-nephropathy decision tool indiscriminately to every nephrotic patient. [\[1\]](#cite-1 "Reference [1]") ### Infection: distinguish disease risk from treatment risk Nephrotic patients face infection risk, including invasive pneumococcal disease; immunosuppression can increase that risk further. Review pneumococcal and influenza vaccination, and evaluate fever, abdominal pain, or rapidly worsening erythema promptly rather than attributing every symptom to edema. Before immunosuppression, assess relevant latent or chronic infections and consider treatment-specific prophylaxis. [\[4\]](#cite-4 "Reference [4]") Key Takeaways ------------- - **More than 3.5 g/day** defines nephrotic-range proteinuria, not the underlying diagnosis. - For edema, restrict sodium, use a loop diuretic when needed, and monitor for volume depletion and AKI. - Investigate suspected VTE urgently; individualize *preventive* anticoagulation rather than prescribing it automatically. - Address vaccination and infection assessment before immunosuppressive treatment. [\[2\]](#cite-2 "Reference [2]") Conclusion ---------- Nephrotic syndrome is more than a urine protein threshold. Confirm the phenotype, manage edema without sacrificing renal perfusion, and actively look for thrombosis and infection while establishing the cause. [\[4\]](#cite-4 "Reference [4]") Frequently Asked Questions ---------------------------- ### Does proteinuria above 3.5 g/day always mean nephrotic syndrome? No. It establishes nephrotic-range proteinuria; assess serum albumin, edema, and the broader clinical picture before labeling the syndrome. [\[4\]](#cite-4 "Reference [4]") ### Why might edema worsen despite an oral loop diuretic? High sodium intake, impaired oral absorption, and diuretic resistance are possibilities. Reassess volume status and kidney function before escalating treatment. [\[1\]](#cite-1 "Reference [1]") ### Should every adult with nephrotic syndrome receive anticoagulant prophylaxis? No. Balance individual thrombotic risk against bleeding risk; confirmed thrombosis is a separate indication for therapeutic anticoagulation. [\[1\]](#cite-1 "Reference [1]") References (6) ------------------ 1. 1. [ KDIGO. Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney International, 2021. ](https://kdigo.org/wp-content/uploads/2021/10/KDIGO-2021-Guideline-for-the-Management-of-Glomerular-Diseases.pdf) [↩](#cite-ref-1-1 "Back to text") 2. 2. [ www.merckmanuals.com/professional/nephrology/symptoms-of-nephrologic-disorders/proteinuria ](https://www.merckmanuals.com/professional/nephrology/symptoms-of-nephrologic-disorders/proteinuria) [↩](#cite-ref-2-1 "Back to text") 3. 3. [ www.merckmanuals.com/professional/nephrology/glomerular-disorders/overview-of-nephrotic-syndrome ](https://www.merckmanuals.com/professional/nephrology/glomerular-disorders/overview-of-nephrotic-syndrome) [↩](#cite-ref-3-1 "Back to text") 4. 4. [ kdigo.org/wp-content/uploads/2017/02/KDIGO-Glomerular-Diseases-Guideline-2021-English.pdf ](https://kdigo.org/wp-content/uploads/2017/02/KDIGO-Glomerular-Diseases-Guideline-2021-English.pdf) [↩](#cite-ref-4-1 "Back to text") 5. 5. [ kdigo.org/wp-content/uploads/2017/02/KDIGO-2021-Glomerular-Diseases-Guideline\_English\_LN-2024-Update.pdf ](https://kdigo.org/wp-content/uploads/2017/02/KDIGO-2021-Glomerular-Diseases-Guideline_English_LN-2024-Update.pdf) [↩](#cite-ref-5-1 "Back to text") 6. 6. [ KDIGO. Glomerular Diseases guideline updates and resources. ](https://kdigo.org/guidelines/gd/) Study pathway Turn reading into Internal Medicine performance ------------------------------------------------- - System‑based, exam‑style questions + explanations - Smarter review to reinforce weak topics - Build confidence with measurable progress Free 5-day trial No credit card required. [ Start practicing ](https://mdster.com/user/dashboard) [ Explore Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ View pricing ](https://mdster.com/pricing) [ Explore features ](https://mdster.com/features) No credit card required. Full access to all features\*. No commitment. Cancel anytime. \*AI SOE Examiner is limited to 10 cases monthly for Advanced & Bundle subscribers. Explore topics: [ # Internal Medicine ](https://mdster.com/blog?tag=internal-medicine) [ # Nephrology ](https://mdster.com/blog?tag=nephrology) [ # Glomerular Disease ](https://mdster.com/blog?tag=glomerular-disease) [ # Proteinuria ](https://mdster.com/blog?tag=proteinuria) [ Back to all posts ](https://mdster.com/blog) Discussion () ----------------- Join the discussion [ Log in ](https://mdster.com/auth/login) or [ Sign up ](https://mdster.com/auth/register) No comments yet Be the first to share your thoughts! ![]() More in Medical Education ------------------------- [ See all ](https://mdster.com/blog?category=medical-education) [### Neurocutaneous Syndromes in Pediatrics: Three Screening Priorities 6 min read Sep 30, 2026 ](https://mdster.com/blog/neurocutaneous-syndromes-in-pediatrics-three-screening-priorities) [### ECT Physiology and Anesthetic Technique: Airway, Seizure, Surge 6 min read Sep 29, 2026 ](https://mdster.com/blog/ect-physiology-and-anesthetic-technique-airway-seizure-surge) [### EMS Documentation and Medico-Legal Oversight: Handoffs and Refusals 6 min read Sep 28, 2026 ](https://mdster.com/blog/ems-documentation-and-medico-legal-oversight-handoffs-and-refusals) Related Posts ------------- [ ![Neurocutaneous Syndromes in Pediatrics: Three Screening Priorities](https://mdster.com/storage/blog/images/neurocutaneous-syndromes-in-pediatrics-three-screening-priorities.png) Medical Education ### Neurocutaneous Syndromes in Pediatrics: Three Screening Priorities A practical pediatric approach to NF1 surveillance, Sturge–Weber vascular malformations, and tuberous sclerosis–associated seizures, with the pitfalls that matter on rounds. 6 min read 0 comments ](https://mdster.com/blog/neurocutaneous-syndromes-in-pediatrics-three-screening-priorities) [ ![ECT Physiology and Anesthetic Technique: Airway, Seizure, Surge](https://mdster.com/storage/blog/images/ect-physiology-and-anesthetic-technique-airway-seizure-surge.png) Medical Education ### ECT Physiology and Anesthetic Technique: Airway, Seizure, Surge ECT lasts minutes, but airway failure, an inadequate seizure, or a cardiovascular surge can change the case. Learn how to plan the anesthetic around all three. 6 min read 0 comments ](https://mdster.com/blog/ect-physiology-and-anesthetic-technique-airway-seizure-surge) [ ![EMS Documentation and Medico-Legal Oversight: Handoffs and Refusals](https://mdster.com/storage/blog/images/ems-documentation-and-medico-legal-oversight-handoffs-and-refusals.png) Medical Education ### EMS Documentation and Medico-Legal Oversight: Handoffs and Refusals Follow a patient from field assessment to ED handoff, safety-event review, or informed refusal—and learn what EMS documentation must preserve at each decision point. 6 min read 0 comments ](https://mdster.com/blog/ems-documentation-and-medico-legal-oversight-handoffs-and-refusals) [ ![Membership of the Royal Colleges of Physicians of the United Kingdom (MRCP(UK) Part 1): A Practical Study Plan](https://mdster.com/storage/blog/images/membership-of-the-royal-colleges-of-physicians-of-the-united-kingdom-mrcpuk-part-1-a-pract.png) Study Tips ### Membership of the Royal Colleges of Physicians of the United Kingdom (MRCP(UK) Part 1): A Practical Study Plan Build a realistic MRCP(UK) Part 1 plan around the official blueprint, best-of-five practice and timed papers—without letting question volume replace careful review. 6 min read 0 comments ](https://mdster.com/blog/membership-of-the-royal-colleges-of-physicians-of-the-united-kingdom-mrcpuk-part-1-a-pract) [ ![Restraints Ethics and Safety in the Medically Ill and ICU Patient](https://mdster.com/storage/blog/images/restraints-ethics-and-safety-in-the-medically-ill-and-icu-patient.png) Medical Education ### Restraints Ethics and Safety in the Medically Ill and ICU Patient When an agitated ICU patient reaches for a breathing tube, restraint may seem inevitable. Learn how to protect immediate safety without overlooking delirium, trauma, or patient rights. 5 min read 0 comments ](https://mdster.com/blog/restraints-ethics-and-safety-in-the-medically-ill-and-icu-patient) [ ![Opioid Tapering and Transitions: A Family Medicine Safety Guide](https://mdster.com/storage/blog/images/opioid-tapering-and-transitions-a-family-medicine-safety-guide.png) Medical Education ### Opioid Tapering and Transitions: A Family Medicine Safety Guide A practical guide to patient-centered opioid tapers, withdrawal management, buprenorphine transitions, and referral decisions in family medicine. 6 min read 0 comments ](https://mdster.com/blog/opioid-tapering-and-transitions-a-family-medicine-safety-guide) [ MDster home ](/ "MDster home") Master your medical exams with evidence-based learning. [ Download on the App Store ](https://apps.apple.com/app/id6759168258) [ GET IT ON Google Play ](https://play.google.com/store/apps/details?id=com.mdster.app) Platform - [Home](https://mdster.com) - [Features](https://mdster.com/features) - [Pricing](https://mdster.com/pricing) - [About](https://mdster.com/about) Resources - [Blog](https://mdster.com/blog) - [Curriculum](https://mdster.com/curriculum) - [Dashboard](https://mdster.com/user/dashboard) Support - [Contact](https://mdster.com/contact) - [Legal & Policies](https://mdster.com/legal) - [Medical Reviewers](https://mdster.com/medical-reviewers) © 2026 MDster [Terms](https://mdster.com/terms) [Privacy](https://mdster.com/privacy) [Editorial](https://mdster.com/editorial-policy) [ ](https://apps.apple.com/app/id6759168258) [ ](https://play.google.com/store/apps/details?id=com.mdster.app) reCAPTCHA Protected by reCAPTCHA. Google [Privacy Policy](https://policies.google.com/privacy) and [Terms of Service](https://policies.google.com/terms) apply. Cookie Consent -------------- We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. [ Terms of Use ](https://mdster.com/terms) & [ Privacy Policy ](https://mdster.com/privacy) Accept